Adalimumab for Nail Psoriasis: Efficacy and Safety from the Open-Label Extension of a Phase-3, Randomized, Placebo-Controlled Trial
Alice B Gottlieb, Boni E Elewski, Martin M Okun, Jerry Bagel, Yves Poulin, Yihua Gu, Ziqian Geng, David A Williams, Wendell C Valdecantos
Abstract Not Available
Disclosures: Study supported by AbbVie.
adalimumab; nail disorders; psoriasis; nail psoriasis
Abstract - 140 Poster PDF - 30
- There are currently no refbacks.